My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
MEDICA TESTING GROUP, INC.
Clerk
>
Contracts / Agreements
>
M
>
MEDICA TESTING GROUP, INC.
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/23/2021 3:52:20 PM
Creation date
8/18/2020 10:26:36 AM
Metadata
Fields
Template:
Contracts
Company Name
MEDICA TESTING GROUP, INC.
Contract #
A-2020-158-08
Agency
City Manager's Office
Council Approval Date
8/4/2020
Expiration Date
10/10/2020
Insurance Exp Date
1/1/2021
Destruction Year
2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
34
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
SUBRECIPIENT, until such documentation and reporting has been received and approved by <br />CITY. <br />(1) Reduction in CARES Act Funding. The CITY reserves the right to reduce the <br />amount of CARES Act Funds to SUBRECIPIENT, or to completely terminate this Agreement, in <br />the CITY's sole discretion, if there is a reduction in CARES Act Funds provided to the CITY, <br />provided that the City will pay SUBRECIPIENT for all COVID-19 tests actually performed prior <br />to SUBRECIPIENT receiving notice from the CITY of any reduction in CARES Act Funding or <br />termination of this Agreement. <br />(2) Reduced Distribution of Funds. The CITY reserves the right to reduce the <br />grant application if the CITY's fiscal monitoring indicates that SUBRECIPIENT's rate of <br />expenditure will result in unspent funds at the end of the program term. Amendments in the grant <br />allocation will be made after consultation with SUBRECIPIENT. <br />E. Grant Program Requirements. <br />(1) SUBRECIPIENT acknowledges that the source of funding for said program is the <br />federal CARES Act Fund, and that payments from the CARES Act Funds are only to be used to make <br />necessary expenditures incurred due to the public health emergency with respect to COVID-1.9. <br />(2) SUBRECIPIENT acknowledges that CARES Act Fund provisions allow the use <br />of CARES Act Funds for expenses associated with the COVID-19 public health emergency, such as <br />expenditures related to COVID-19 testing and contact tracing, and will not use these funds for any <br />other uses <br />(3) SUBRECIPIENT shall follow the process and determination of eligibility for <br />participants in said programs as outlined in Exhibit A. <br />F. Performance Monitoring. <br />(1) SUBRECIPIENT shall submit program performance information as often as <br />requested by CITY, but no less than the submission of weekly activity reports and a final report to <br />CITY with the information requested by and in the format acceptable to CITY. The final report is <br />due within thirty (30) days after the termination or expiration of this Agreement. <br />(2) CITY will evaluate SUBRECIPIENT's management and operation of said <br />programs on factors and requirements as described in Exhibit A. <br />(3) CITY will review the audit of the SUBRECIPIENT to ensure that grant funds are <br />used for authorized purposes in compliance with laws, regulations, and the provisions under this <br />Agreement, including attachments and exhibits. <br />(4) If action to correct any substandard performance is not taken by the <br />SUBRECIPIENT within a reasonable period after being notified by CITY, suspension or termination <br />procedures may be initiated by CITY. <br />
The URL can be used to link to this page
Your browser does not support the video tag.